The total number of records retrieved from this search are 10. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_5146	Virus nameSemliki forest virus	Virus strainwild type SFV4	Virus genome typeRNA	Virus familyAlphaviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineMurine glioma cell line	Cell lineCT-2A	Concentration of cell line20000 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration0.001 MOI	In-vitro result5% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectInduce production of IFN gamma	Clinical trialNA	PMID27637889
IDOV_5147	Virus nameSemliki forest virus	Virus strainwild type SFV4	Virus genome typeRNA	Virus familyAlphaviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineMurine glioma cell line	Cell lineCT-2A	Concentration of cell line20000 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration0.01 MOI	In-vitro result5% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectInduce production of IFN gamma	Clinical trialNA	PMID27637889
IDOV_5148	Virus nameSemliki forest virus	Virus strainwild type SFV4	Virus genome typeRNA	Virus familyAlphaviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineMurine glioma cell line	Cell lineCT-2A	Concentration of cell line20000 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration0.1 MOI	In-vitro result5% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectInduce production of IFN gamma	Clinical trialNA	PMID27637889
IDOV_5149	Virus nameSemliki forest virus	Virus strainwild type SFV4	Virus genome typeRNA	Virus familyAlphaviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineMurine glioma cell line	Cell lineCT-2A	Concentration of cell line20000 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration1 MOI	In-vitro result5% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectInduce production of IFN gamma	Clinical trialNA	PMID27637889
IDOV_5150	Virus nameSemliki forest virus	Virus strainwild type SFV4	Virus genome typeRNA	Virus familyAlphaviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineMurine glioma cell line	Cell lineCT-2A	Concentration of cell line20000 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration10 MOI	In-vitro result5% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectInduce production of IFN gamma	Clinical trialNA	PMID27637889
IDOV_5151	Virus nameSemliki forest virus	Virus strainSFVmiRT	Virus genome typeRNA	Virus familyAlphaviridae	Virus genome modificationInsertional mutagenesis at 3UTr for miR124, 125 and 134	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineMurine glioma cell line	Cell lineCT-2A	Concentration of cell line20000 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration0.001 MOI	In-vitro result5% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectInduce production of IFN gamma	Clinical trialNA	PMID27637889
IDOV_5152	Virus nameSemliki forest virus	Virus strainSFVmiRT	Virus genome typeRNA	Virus familyAlphaviridae	Virus genome modificationInsertional mutagenesis at 3UTr for miR124, 125 and 134	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineMurine glioma cell line	Cell lineCT-2A	Concentration of cell line20000 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration0.01 MOI	In-vitro result5% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectInduce production of IFN gamma	Clinical trialNA	PMID27637889
IDOV_5153	Virus nameSemliki forest virus	Virus strainSFVmiRT	Virus genome typeRNA	Virus familyAlphaviridae	Virus genome modificationInsertional mutagenesis at 3UTr for miR124, 125 and 134	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineMurine glioma cell line	Cell lineCT-2A	Concentration of cell line20000 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration0.1 MOI	In-vitro result5% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectInduce production of IFN gamma	Clinical trialNA	PMID27637889
IDOV_5154	Virus nameSemliki forest virus	Virus strainSFVmiRT	Virus genome typeRNA	Virus familyAlphaviridae	Virus genome modificationInsertional mutagenesis at 3UTr for miR124, 125 and 134	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineMurine glioma cell line	Cell lineCT-2A	Concentration of cell line20000 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration1 MOI	In-vitro result5% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectInduce production of IFN gamma	Clinical trialNA	PMID27637889
IDOV_5155	Virus nameSemliki forest virus	Virus strainSFVmiRT	Virus genome typeRNA	Virus familyAlphaviridae	Virus genome modificationInsertional mutagenesis at 3UTr for miR124, 125 and 134	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineMurine glioma cell line	Cell lineCT-2A	Concentration of cell line20000 cells per well	In-vitro toxicityNA	AssayMTS assay	In-vitro virus concentration10 MOI	In-vitro result5% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectInduce production of IFN gamma	Clinical trialNA	PMID27637889